Related references
Note: Only part of the references are listed.Absence of Severe Complications From SARS-CoV-2 Infection in Children With Rheumatic Diseases Treated With Biologic Drugs
Giovanni Filocamo et al.
JOURNAL OF RHEUMATOLOGY (2021)
Dexamethasone in Hospitalized Patients with Covid-19
Peter Horby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Insights on the Evidence of Cardiotoxicity of Hydroxychloroquine Prior and During COVID-19 Epidemic
Serena Romani et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)
Coronavirus disease 2019 in patients with inborn errors of immunity: An international study
Isabelle Meyts et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Rheumatic disease and COVID-19: epidemiology and outcomes
Kimme L. Hyrich et al.
NATURE REVIEWS RHEUMATOLOGY (2021)
COVID-19 in Autoinflammatory Diseases with Immunosuppressive Treatment
Tatjana Welzel et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus
Zhi-Min Chen et al.
WORLD JOURNAL OF PEDIATRICS (2020)
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
Timothy P. Sheahan et al.
NATURE COMMUNICATIONS (2020)
Recommendations on the clinical management of the COVID-19 infection by the new coronavirus SARS-CoV2. Spanish Paediatric Association working group
Cristina Calvo et al.
ANALES DE PEDIATRIA (2020)
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19
Maximilian F. Konig et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
Sara Monti et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Cardiovascular Toxicities Associated With Hydroxychloroquine and Azithromycin An Analysis of the World Health Organization Pharmacovigilance Database
Lee S. Nguyen et al.
CIRCULATION (2020)
COVID-19-Considerations for the paediatric rheumatologist
Christian M. Hedrich
CLINICAL IMMUNOLOGY (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Interleukin-1 receptor antagonist anakinra in association with remdesivir in severe COVID-19: A case report
Marco Franzetti et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
COVID-19 illness in native and immunosuppressed states: A clinical?therapeutic staging proposal
Hasan K. Siddiqi et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)
How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review
Chiara Minotti et al.
JOURNAL OF INFECTION (2020)
Impacts of immunosuppression and immunodeficiency on COVID-19: A systematic review and meta-analysis
Ya Gao et al.
JOURNAL OF INFECTION (2020)
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
Wei Tang et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Features of 20133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study
Annemarie B. Docherty et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
Lucio Verdoni et al.
LANCET (2020)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents A Systematic Review
Riccardo Castagnoli et al.
JAMA PEDIATRICS (2020)
A Call for Pediatric COVID-19 Clinical Trials
Jeffrey I. Campbell et al.
PEDIATRICS (2020)
COVID-19: Immunology and treatment options
Susanna Felsenstein et al.
CLINICAL IMMUNOLOGY (2020)
EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2
Robert B. M. Landewe et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study
Sofia Ramiro et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohort
Marie Pouletty et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020
Alexandre Belot et al.
EUROSURVEILLANCE (2020)
American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 1
Dawn M. Wahezi et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Clinical Characteristics of Children With COVID-19: A Meta-Analysis
Yudan Ding et al.
FRONTIERS IN PEDIATRICS (2020)
Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review
Saeed K. Alzghari et al.
JOURNAL OF CLINICAL VIROLOGY (2020)
The severity of COVID-19 in children on immunosuppressive medication
Matko Marlais et al.
LANCET CHILD & ADOLESCENT HEALTH (2020)
Treatments Administered to the First 9152 Reported Cases of COVID-19: A Systematic Review
David C. Fajgenbaum et al.
INFECTIOUS DISEASES AND THERAPY (2020)
Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic
Fatih Haslak et al.
RHEUMATOLOGY INTERNATIONAL (2020)
Implications of COVID-19 in pediatric rheumatology
Ezgi Deniz Batu et al.
RHEUMATOLOGY INTERNATIONAL (2020)
COVID-19 in systemic lupus erythematosus: Data from a survey on 417 patients
Giuseppe A. Ramirez et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)
Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs
Xabier Michelena et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)
Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS CoV-2
Caroline Diorio et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial
Remo H. M. Furtado et al.
LANCET (2020)
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
Qian Zhang et al.
SCIENCE (2020)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard et al.
SCIENCE (2020)
COVID-19: treatment strategies of German-speaking pediatric rheumatologists Results of an online survey
A. Janda et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE (2020)
Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score
Stephen R. Knight et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study
Olivia Swann et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project)
Sophie Juul et al.
PLOS MEDICINE (2020)
How the COVID-19 pandemic has influenced pediatric rheumatology practice: Results of a global, cross-sectional, online survey
Ezgi Deniz Batu et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)
Reporting Survey Based Studies - a Primer for Authors
Prithvi Sanjeevkumar Gaur et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2020)
SARS-CoV-2 infections in children and young people
Susanna Felsenstein et al.
CLINICAL IMMUNOLOGY (2020)
Clinical Characteristics and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Italian Pediatric Oncology Patients: A Study From the Infectious Diseases Working Group of the Associazione Italiana di Oncologia e Ematologia Pediatrica
Gianni Bisogno et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2020)
Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis
Awadhesh Kumar Singh et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
First case of COVID-19 in a patient with multiple myeloma successfully treated with tocilizumab
Xuhan Zhang et al.
BLOOD ADVANCES (2020)
Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial
Bita Shakoory et al.
CRITICAL CARE MEDICINE (2016)
Medicinal prophylaxis during intensified immunosuppression in children and adolescents. Part 2
F. Speth et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE (2013)
Screening investigations during intensified immunosuppression in children and adolescents.1
F. Speth et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE (2013)
Share Paper
